Colesevelam Effective as Add-On Therapy in Type 2 Diabetes
Colesevelam (Welchol, Daiichi-Sankyo Pharmaceuticals) might not be a first choice for many clinicians in the treatment of type 2 diabetes; however, a post hoc analysis of three large randomized controlled trials reveals that it might be a good option as an add-on therapy for patients with both type 2 diabetes and high cholesterol. \"For patients who need to both lower blood sugar and cholesterol, colesevelam is a nice addition,\" said George Grunberger, MD, FACP, FACE, chair of the Grunberger Diabetes Institute and professor of internal medicine and molecular genetics at Wayne State University School of Medicine. \"The advantages of colesevelam are that there\'s no hypoglycemia and no weight gain, and it\'s taken by mouth. So the ideal person is one who cannot tolerate statins or is on statins but still needs a little push,\" he observed.